Mark A. Hlatky, MD, FACC, et al., sought to determine the economic and quality of life benefits of evaluating stable patients with suspected CAD through fractional flow reserve estimated by CT, compared with usual care. In this multi-center, prospective, non-randomized study, 100 patients were evaluated with non-invasive testing, while 104 were evaluated with fractional flow reserve estimated by CT. In the invasive testing group, 187 patients received the usual care strategy and 193 patients were evaluated by fractional flow reserve estimated by CT.

The results of the study show that evaluation of fractional flow reserve estimated by CT is associated with lower costs and improved quality of life in stable suspected CAD patients, compared to evaluation with invasive coronary angiography and other noninvasive testing, respectively. Evaluation of these patients with fractional flow reserve estimated by CT also resulted in lower use of medical resources, compared to invasive coronary angiography.

According to Hlatky, et al., “these findings suggest that the combination of anatomic and functional data provided by the fractional flow reserve estimated by CT guided testing strategy may lead to more selective use of invasive procedures than relying solely on the anatomic data provided by invasive coronary angiography.”